DC isoketal-modified proteins activate T cells and promote hypertension A Kirabo, V Fontana, APC De Faria, R Loperena, CL Galindo, J Wu, ... The Journal of clinical investigation 124 (10), 4642-4656, 2014 | 547 | 2014 |
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study JJ Swen, CH van der Wouden, LEN Manson, H Abdullah-Koolmees, ... The Lancet 401 (10374), 347-356, 2023 | 225 | 2023 |
36th international symposium on intensive care and emergency medicine: Brussels, Belgium. 15-18 March 2016 RM Bateman, MD Sharpe, JE Jagger, CG Ellis, J Solé-Violán, ... Critical care 20, 13-182, 2016 | 175 | 2016 |
Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers NR Barbaro, V Fontana, R Modolo, AP De Faria, AR Sabbatini, ... Blood pressure 24 (1), 7-13, 2015 | 124 | 2015 |
Circulating matrix metalloproteinases and their inhibitors in hypertension V Fontana, PS Silva, RF Gerlach, JE Tanus-Santos Clinica Chimica Acta 413 (7-8), 656-662, 2012 | 114 | 2012 |
Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase‐2 activity and expression in a model of renovascular hypertension CS Ceron, MM Castro, E Rizzi, MF Montenegro, V Fontana, MCO Salgado, ... British journal of pharmacology 160 (1), 77-87, 2010 | 110 | 2010 |
An update on the role of adipokines in arterial stiffness and hypertension AR Sabbatini, V Fontana, S Laurent, H Moreno Journal of hypertension 33 (3), 435-444, 2015 | 65 | 2015 |
Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: a relevant pharmacological target V Fontana, PS Silva, VA Belo, RC Antonio, CS Ceron, C Biagi, ... Basic & clinical pharmacology & toxicology 109 (2), 130-137, 2011 | 64 | 2011 |
eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril PS Silva, V Fontana, MR Luizon, R Lacchini, WA Silva, C Biagi, ... European journal of clinical pharmacology 69, 167-177, 2013 | 60 | 2013 |
Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension APC de Faria, C Demacq, VN Figueiredo, CH Moraes, RC Santos, ... Hypertension Research 36 (12), 1067-1072, 2013 | 57 | 2013 |
Deregulation of adipokines related to target organ damage on resistant hypertension AR Sabbatini, AP Faria, NR Barbaro, WM Gordo, RGP Modolo, C Pinho, ... Journal of human hypertension 28 (6), 388-392, 2014 | 56 | 2014 |
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity F Di Pisa, G Landi, L Dello Iacono, C Pozzi, C Borsari, S Ferrari, ... Molecules 22 (3), 426, 2017 | 52 | 2017 |
An update on the pharmacogenetics of treating hypertension V Fontana, MR Luizon, VC Sandrim Journal of human hypertension 29 (5), 283-291, 2015 | 50 | 2015 |
Vascular Damage in Resistant Hypertension: TNF‐Alpha Inhibition Effects on Endothelial Cells NR Barbaro, TM de Araújo, JE Tanus-Santos, GF Anhê, V Fontana, ... BioMed research international 2015 (1), 631594, 2015 | 48 | 2015 |
Adipokines: novel players in resistant hypertension AP De Faria, R Modolo, V Fontana, H Moreno The Journal of Clinical Hypertension 16 (10), 754-759, 2014 | 48 | 2014 |
Large‐scale gene‐centric analysis identifies polymorphisms for resistant hypertension V Fontana, CW McDonough, Y Gong, NM El Rouby, ACC Sá, KD Taylor, ... Journal of the American Heart Association 3 (6), e001398, 2014 | 45 | 2014 |
Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension APC de Faria, V Fontana, R Modolo, NR Barbaro, AR Sabbatini, ... Clinica Chimica Acta 433, 179-183, 2014 | 42 | 2014 |
Modulation of aldosterone levels by− 344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertension V Fontana, APC de Faria, NR Barbaro, AR Sabbatini, R Modolo, ... Journal of the American Society of Hypertension 8 (3), 146-151, 2014 | 36 | 2014 |
A genome‐wide association study of circulating levels of atorvastatin and its major metabolites RM Turner, V Fontana, JE Zhang, D Carr, P Yin, R FitzGerald, AP Morris, ... Clinical Pharmacology & Therapeutics 108 (2), 287-297, 2020 | 35 | 2020 |
Gene–Gene Interactions Among PRKCA, NOS3 and BDKRB2 Polymorphisms Affect the Antihypertensive Effects of Enalapril GH Oliveira‐Paula, MR Luizon, R Lacchini, V Fontana, PS Silva, C Biagi, ... Basic & Clinical Pharmacology & Toxicology 120 (3), 284-291, 2017 | 35 | 2017 |